Subscrib

Log In

How serious is FDA warning about revolutionary blood-cancer

How serious is FDA warning about revolutionary blood-cancer

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

FDA Investigates T-Cell Malignancy Risk Linked to CAR T-Cell Therapies

US FDA approves Pfizer's blood cancer therapy

Oncology Health Central

CAR-T Therapy: The Future of Regenerative Immunotherapy - OriGen Biomedical

Matty B Biotech

Mark Flower on LinkedIn: #celltherapy #cryopreservation #apheresis #donoridentification…

FDA warns against widely used ovarian cancer screening test

Oncology/Hematology Leukemiaarticles page [1]

Jason King on LinkedIn: Researchers use CAR-T gel to kill leftover cancer cells after surgery

Blood Cancer Treatment Could Be Linked to Cancer: FDA

Revolutionary four-biomarker panel offers hope for early ovarian cancer detection

Immune-Onc's antibody therapy collects second FDA orphan designation - Pharmaceutical Technology

James Wang, PhD on LinkedIn: Bispecific CAR T-Cell Therapy Has “Robust” Activity in Non-Hodgkin Lymphoma

How serious is FDA warning about revolutionary blood-cancer treatment?— Harvard Gazette